Hematology Diagnostics Market Share To Reach USD 11.16 Billion By 2028 | Increasing adoption of Automated Hematology Diagnostic Systems.
Rising prevalence of blood cancers such as leukemia and growing awareness about advanced hematology diagnostics are some key factors driving market revenue growth
Hematology Diagnostics Market Size – USD 7.10 billion in 2020,
Market Growth – at a CAGR of 5.87%, Market Trends – Increasing adoption of
automated hematology diagnostic systems
The
global Hematology
Diagnostics Market size is expected to reach USD 11.16 billion in 2028
at a CAGR of 5.87%, according to the latest report by Reports and Data. Global
market revenue growth is majorly driven by surging prevalence of blood-associated
disorders such as anemia, myelofibrosis, thalassemia, and malignant lymphomas,
increased adoption of advanced hematology diagnostic techniques, and rising
number of procedures including blood transfusion and bone marrow stem cell
transplantation, and automation in hematology diagnostic procedures such as
test identification and sample collection and processing.
Get a sample of the report @ https://www.reportsanddata.com/discount-enquiry-form/4057
Hematology
refers to the scientific study of blood and blood-related disorders. Hematology
diagnostics include a wide range of hematology tests and require samples of
whole blood, serum, urine, and other bodily fluids for proper disease
diagnosis. These tests are based on in vitro diagnostic technologies such as
hemostasis, blood analysis, immunodiagnostics, flow cytometry, and molecular
diagnostics. These tests are widely performed to accurate diagnose various
blood-related disorders such as anemia, bleeding disorders like blood clots and
hemophila, and blood cancers including leukemia. Hence, hemostatis, hematology
reagents, immunohematology, and hematology rapid tests are among the most
common hematology diagnostic tests.
Some
Key Highlights From the Report:
- Based
on product type, the consumables segment is projected to account for
largest revenue share in the global hematology diagnostics market over the
forecast period. Growing healthcare burden of blood-related disorders
worldwide, rise in demand for early and accurate disease diagnosis,
surging use of hematology consumables, and increasing volumes of
hematological tests are among some key factors driving growth of the
consumables segment.
- The
diagnostic laboratories segment is the leading end-use segment and is
projected to register highest revenue growth rate over the forecast
period. This segment’s growth is primarily attributed to growing
prevalence of blood-related diseases, surging number of diagnostic
laboratories, and technological advancements in hematology diagnostic
techniques.
- North
America is expected to continue to remain the leader in terms of revenue
share contribution among other regional markets in the global hematology
diagnostics market over the forecast period. Key factors bolstering North
America market growth are surging prevalence of blood-related disorders,
increasing volumes of hematological tests, and technological advances in
diagnostic The region’s state-of-the-art healthcare infrastructure and
rise in healthcare expenditure is further expected to support North
America market revenue growth.
- Abbott
Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Sysmex
Corporation, Beckman Coulter, Inc., Mindray Medical International Limited,
HemoCue AB, Bio-Rad Laboratories Inc., Boule Diagnostics, Horiba
Ltd., EKF Diagnostics, Drew Scientific Inc., Nihon Kohden
Corporation, and Ortho Clinical Diagnostics are major companies operating
in the global market.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4057
For
the purpose of this report, the global hematology diagnostics market has been
segmented based on the product type, test type, end-use, and region:
By Product Type (Revenue, USD Billion; 2018-2028)
- Instruments
- Analyzers
- Flow
Cytometers
- Others
- Reagents
- Consumables
- Stains
- Others
By Test Type (Revenue, USD Billion; 2018-2028)
- Full
Blood Count Testing
- Red
Blood Cells (RBC) Testing
- White
Blood Cells (WBC) Testing
- Hemoglobin
Testing
- Hematocrit
and Platelets
- Blood
Glucose Testing
- Renal
Profiling
- Vitamin
B12 Deficiency Testing
- Others
By End-user (Revenue, USD Billion; 2018-2028)
- Hospitals
& Clinics
- Diagnostic
Laboratories
- Others
To know more about the report @ https://www.reportsanddata.com/report-detail/hematology-diagnostics-market
By Region (Revenue, USD Billion; 2018-2028)
- North
America
- S.
- Canada
- Europe
- Germany
- K.
- France
- BENELUX
- Rest
of Europe
- Asia
Pacific
- China
- Japan
- India
- South
Korea
- Rest
of the Asia Pacific
- Latin
America
- Brazil
- Rest
of Latin America
- Middle
East & Africa
- Saudi
Arabia
- UAE
- Rest
of the Middle East & Africa
Radical Features of the Report:
- Offers
a comprehensive overview of the Hematology Diagnostics market along with
product portfolio and supply chain assessment
- Complete
analysis of the competitive landscape including expansion strategies,
product portfolio, production capacity, and strategic initiatives
- Extensive
analysis of market drivers, constraints, suppliers and distributors,
limitations, opportunities, marketing and production, and other key
segments
- SWOT
analysis and Porter’s Five Forces analysis to offer accurate insights
- Complete
coverage of key technological developments, market trends, and product
developments
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4057
Thank
you for reading our report. Customization of the report is available as per
client’s needs. Please get in touch with us and our team will ensure you get
the report tailored as per your requirements.
Table of content
Chapter 1. Methodology and Scope
1.1. Market
Segmentation & Scope
1.2.
Market Definition
1.3.
Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-party Perspectives
1.3.4. Primary Research
1.4.
Information Analysis
1.4.1. Data Analysis Models
1.5.
Market Formulation & Data Visualization
1.6. Data
Validation & Publishing
Chapter 2. Executive
Summary
2.1.
Market Outlook
2.2.
Material Type Outlook
2.3.
Application Outlook
2.4.
Regional Insights
Chapter 3. Hematology
Diagnostics Market Variables, Trends & Scope
3.1.
Market Introduction
3.2.
Penetration & Growth Prospect Mapping
3.3.
Industry Value Chain Analysis
3.3.1. Sales/Retail Channel Analysis
3.3.2. Profit Margin Analysis
3.4.
Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5.
Business Environment Analysis
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6.
Roadmap of Hematology Diagnostics Market
3.7.
Market Entry Strategies
Chapter 4. Consumer
Behavior Analysis
4.1.
Consumer Trends and Preferences
4.2.
Consumer Calorie Perception
4.3.
Factors Affecting Buying Decision
4.4.
Consumer Product Adoption
4.5.
Observations & Recommendations
Chapter 5. Hematology Diagnostics Market: Product Type Estimates
& Trend Analysis
Continued....
Comments
Post a Comment